Nordisks

Novo Nordisk’s obesity drug Wegovy cleared to treat live disease MASH

Novo Nordisk’s obesity drug Wegovy has received approval from U.S. regulators to treat metabolic dysfunction-associated steatohepatitis (MASH), a common liver…

Read More »